Hypertension and Diabetes Assessment in the Rohingya Refugee Population and in the Host Communities in Bangladesh
NCT ID: NCT04307875
Last Updated: 2021-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
3000 participants
OBSERVATIONAL
2021-10-01
2022-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
According to previous examinations, there is a serious burden of non-communicable diseases in Bangladesh. But little is known about the health status and the epidemiology of non-communicable diseases in the Rohingya refugee population in Bangladesh. Most importantly, scientific evidence on non-communicable disease in humanitarian emergencies is rather limited.
The aim of this study is to close this gap and to systematically assess the burden of hypertension and diabetes within the Rohingya refugee population in refugee camps in Bangladesh and in the host community in the Chittagong province. This assessment will help to design and to introduce community-based intervention strategies aiming to improve the population health status and reduce the disease burden.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Retinal Function in Relation to Glucose Changes
NCT00973726
The Electroretinogram in Healthy and Glucose Intolerant Young Men
NCT01140932
Effect of Acute Hyperglycemia on Renal Tissue Oxygenation
NCT02346149
Interaction of Muscle Dystrophy, Glucose Metabolism and Insulin Sensitivity
NCT05052073
Identification of the Epigenetic Response to Trauma
NCT03974048
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Due to a massive outbreak of violence against people of the Rohingya minority in the Rakhine state of Myanmar in late 2017 several hundred thousand Rohingya fled the country and sought a refuge in the Chittagong province in south-eastern Bangladesh. These seemingly organized and coordinated attacks have been preceded by massive discrimination and recurrent violence against the Rohingya minority for many decades. Presently, close to 1 million Rohingya refugees settle in the refugee camps in the Chittagong province close to the municipalities of Ukhia and Shamlapur.
Scientific evidence on care of non-communicable diseases (NCDs) in humanitarian emergencies is very limited. A recent systematic review identified only five scientific studies, published between 1980 and 2014 on non-communicable diseases in humanitarian crises. Although many humanitarian organizations from Bangladesh and from abroad organize and support the provision of health services within the refugee camps, systematic evidence on the health status of the Rohingya refugee population is scarce - this is particularly true for chronic and non-communicable diseases.
As in the host community in Bangladesh, there will be a relevant burden of NCDs within the Rohingya refugee population. Furthermore, since the Rohingya have been discriminated for many years and access to health services was restricted for them, many of the diseased will be undiagnosed and untreated and a relevant number of individuals will suffer from long-term complications of untreated disease.
Chittagong province is one of the poorest regions in Bangladesh. Access to primary health services in Bangladesh is limited for many people due to various barriers, affordability being a major reason. A recent observation conducted by Gonoshasthaya Kendra, a project partner in the here presented study, revealed that the distance between place of residence and the nearest health facility and transportation costs are a major obstacle for people in Shamlapur to seek medical care. Data from previous nationwide epidemiologic studies do not sufficiently consider socioeconomic gradients within the Bangladesh population and therefore do not provide substantial information on hypertension and diabetes disease burden in the Rohingya refugee population and the host communities around the refugee camps.
The aim of this study is to systematically assess the burden of hypertension and diabetes mellitus within the Rohingya refugee population in the refugee camps in Bangladesh and in the host community in Chittagong province. This basic epidemiological information is essential for the planning, resource allocation and management of prevention and treatment strategies and programs for the respective populations. Considering the increasing relevance and burden of non-communicable and cardiovascular diseases particularly in low- and middle-income countries, a solid epidemiological data base is a mandatory prerequisite to address this global public health challenge. Therefore, this assessment will help to design and to introduce community-based intervention strategies aiming to improve the population health status and reduce the disease burden.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Rohingya refugee camp population
A sample of 1500 randomly selected individuals aged 18 years and above living in the Rohingya refugee camp 1E.
Blood pressure measurement (sphygmomanometer)
measuring blood pressure with standard sphygmomanometer
Blood glucose measurement
measuring blood glucose using standard measurement devices
psychometric tests
WHODAS 2.0, PHQ-9, CAPS-5
Shamlapur refugee hosting community population
A sample of 1500 randomly selected individuals aged 18 years and above living in the refugee hosting community Shamlapur neighbouring the Rohingya refugee camps.
Blood pressure measurement (sphygmomanometer)
measuring blood pressure with standard sphygmomanometer
Blood glucose measurement
measuring blood glucose using standard measurement devices
psychometric tests
WHODAS 2.0, PHQ-9, CAPS-5
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood pressure measurement (sphygmomanometer)
measuring blood pressure with standard sphygmomanometer
Blood glucose measurement
measuring blood glucose using standard measurement devices
psychometric tests
WHODAS 2.0, PHQ-9, CAPS-5
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥18 years
Exclusion Criteria
* Participant's unwillingness to participate
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heidelberg University
OTHER
Gono Bishwabidyalay
UNKNOWN
Gonoshasthaya Kendra
UNKNOWN
University Hospital Freiburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Alexander Supady
Principal Investigator, Attending Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kashem Shaikh, PhD
Role: PRINCIPAL_INVESTIGATOR
Gono Bishwabidyalay
Alexander Supady, Dr. med. MPH
Role: PRINCIPAL_INVESTIGATOR
University of Freiburg
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
coxs_2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.